Literature DB >> 26328596

Lung Cancer Detected 5 Years after Resection of Cancer of Unknown Primary in a Mediastinal Lymph Node: A Case Report and Review of Relevant Cases from the Literature.

Hidenori Kawasaki1, Kazunari Arakaki, Naohiro Taira, Tomonori Furugen, Takaharu Ichi, Tomofumi Yohena, Tsutomu Kawabata.   

Abstract

We report the rare and interesting case of a primary lung cancer detected 5 years after cancer of unknown primary (CUP) of a mediastinal lymph node (LN) was resected. A 40-year-old male was diagnosed with adenocarcinoma of unknown primary in a mediastinal lymph node after resection of the mediastinal tumor. Five years after resection of the CUP in mediastinal LN, a small, abnormal nodular shadow in left upper lobe was detected by chest CT. This pulmonary tumor was diagnosed as a lung adenocarcinoma. The pathological and immunohistological findings of the resected pulmonary tumor resembled those of the LN resected 5 years before. We speculated that the pulmonary lesion represented primary lung cancer that enlarged later than the metastatic mediastinal LN. This case illustrates the importance of careful observation and long-term follow-up in patients treated for CUP of a thoracic LN.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26328596      PMCID: PMC4936212          DOI: 10.5761/atcs.cr.15-00154

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  10 in total

1.  [Four cases of cancer of unknown primary site that manifested as mediastinal metastatic lesions].

Authors:  F Chen; A Tatsumi; E Nii; H Tanaka; H Muguruma; H Doi; T Nakayama
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  1999-12

Review 2.  Benign epithelial inclusions in axillary lymph nodes: report of 18 cases and review of the literature.

Authors:  Giovanni Fellegara; Maria Luisa Carcangiu; Juan Rosai
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

3.  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  K Fizazi; F A Greco; N Pavlidis; G Pentheroudakis
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

4.  Metastatic cancer of unknown primary site.

Authors:  F F Holmes; T L Fouts
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

Review 5.  [Mediastinal and hilar lymph node of cancer unknown origin: 3 case reports].

Authors:  M Sakuraba; M Mae; T Oonuki; S Nitta
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  1999-01

6.  Metastatic thoracic lymph node carcinoma with unknown primary site.

Authors:  Marc Riquet; Cécile Badoual; Barthes Françoise le Pimpec; Antoine Dujon; Claire Danel
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

7.  Complete spontaneous remission of non-small-cell lung cancer: a case report.

Authors:  M A Cafferata; M Chiaramondia; F Monetti; A Ardizzoni
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

8.  Lymph node cancer of the mediastinal or hilar region with an unknown primary site.

Authors:  S Kohdono; T Ishida; Y Fukuyama; M Hamatake; M Takenoyama; M Tateishi; K Sugimachi
Journal:  J Surg Oncol       Date:  1995-03       Impact factor: 3.454

Review 9.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

  10 in total
  3 in total

1.  Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Authors:  Paul B Romesser; Yonatan Bardash; Darren Buonocore; Jamie E Chaft; James Huang; David R Jones; Andreas Rimner; Abraham J Wu
Journal:  Lung Cancer       Date:  2018-11-17       Impact factor: 5.705

2.  Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report.

Authors:  Daichi Shikata; Takahiro Nakagomi; Rumi Higuchi; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

3.  Thymic Adenocarcinoma with Positivity for Thyroid Transcription Factor-1 and a BRAF V600E Mutation.

Authors:  Takafumi Yorozuya; Mitsuo Otsuka; Shin Ichihara; Kento Fujimori; Chikako Kitamura; Tomoyuki Takahashi; Masaki Mori; Yasushi Cho; Hirofumi Chiba
Journal:  Intern Med       Date:  2021-07-17       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.